Wellmarker Bio(WMBIO) has entered into an agreement with Inje University Paik Hospital to enhance research collaboration for the development of personalized anticancer drugs on April 20, 2022.

The MoU covers a number of areas of cooperation between the two parties which will include ▲ clinical advice (guidance) in developing fit-for-purpose anticancer drugs ▲ establishment of patient-derived models for cancer research and clinical trials ▲ commercialization of research findings ▲ mutual cooperation and information sharing ▲ facilitate knowledge transfer through the exchange of researchers.

By signing this MoU agreement, the two parties have expressed their wishes to enhance their collaboration in common areas of interest by working together towards the development of appropriate, personalized medicine, minimizing side effects whilst maximizing the drug effectiveness.